As 2015 approaches, we would like to again thank you for your continued support and loyalty to the International Society for Sexual Medicine. It is you, the membership community, who drives and shapes the ISSM.

In order to ensure that you will have uninterrupted access to all of ISSM's membership benefits, including the Journal of Sexual Medicine, we kindly ask you to pay your ISSM membership dues for 2015 in a timely manner either through one of our affiliated societies or directly with us through this link. Of course, if you have already paid your membership dues, we thank you.

Also, if your contact information has changed, please take a moment to update it through Your ISSM Membership.

Many men have urinary and sexual issues after prostate cancer treatment. New research suggests that knowing more about possible symptoms ahead of time could help men decide which treatment is best for them.

Researchers from Fox Chase Cancer Center in Philadelphia, USA presented their findings in September at the American Society for Radiation Oncology's 56th Annual Meeting last month.

The researchers compared urinary and sexual symptoms after four types of prostate cancer treatment: intensity modulated radiation therapy (IMRT), low dose rate brachytherapy (LDR), post-prostatectomy IMRT (PPRT), and radical prostatectomy (RP).

Urinary symptoms were assessed in 3,515 men using the American Urological Association Symptom Score. For sexual symptoms, the researchers used the Sexual Health Inventory for Men (SHIM) to evaluate 857 men.

In both scenarios, function was fairly comparable among the groups who had IMRT, LDR, and PPRT. However, men who had RP did not fare as well.

Please click here for more information.